Can less be more? study tests cutting back antibiotics in sepsis
NCT ID NCT01626612
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether it is safe to reduce or narrow antibiotics once doctors know which germ is causing a severe infection (sepsis). 120 intensive care patients were randomly assigned to either continue their original broad antibiotics or switch to a more targeted treatment. The goal was to see if the de-escalation approach could keep patients safe while reducing the risk of drug-resistant infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assistance Publique Hopitaux de Marseille
Marseille, 13354, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking antibiotic levels in the blood improve sepsis care?
- Blood filtering may save children with sepsis
- Sepsis immune cell study ends early
- Can zinc help fight sepsis? early study explores dosing
- New blood marker could speed up sepsis diagnosis in emergency rooms
- Massive data dive aims to tame sepsis in kids